233 related articles for article (PubMed ID: 16263425)
1. Intra-bone marrow transplantation facilitates pauci-clonal human hematopoietic repopulation of NOD/SCID/beta2m(-/-) mice.
Levac K; Menendez P; Bhatia M
Exp Hematol; 2005 Nov; 33(11):1417-26. PubMed ID: 16263425
[TBL] [Abstract][Full Text] [Related]
2. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
[TBL] [Abstract][Full Text] [Related]
3. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
Hogan CJ; Shpall EJ; McNiece I; Keller G
Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
[TBL] [Abstract][Full Text] [Related]
4. Intra-bone marrow transplantation of human CD34(+) cells into NOD/LtSz-scid IL-2rgamma(null) mice permits multilineage engraftment without previous irradiation.
Bueno C; Montes R; de la Cueva T; Gutierrez-Aránda I; Menendez P
Cytotherapy; 2010; 12(1):45-9. PubMed ID: 19929453
[TBL] [Abstract][Full Text] [Related]
5. Enhanced in vivo motility of human umbilical cord blood hematopoietic stem/progenitor cells introduced via intra-bone marrow injection into xenotransplanted NOD/SCID mouse.
Gao J; Li Y; Lu S; Wang M; Yang Z; Yan X; Zheng Y
Exp Hematol; 2009 Aug; 37(8):990-7. PubMed ID: 19481136
[TBL] [Abstract][Full Text] [Related]
6. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells.
Mazurier F; Doedens M; Gan OI; Dick JE
Nat Med; 2003 Jul; 9(7):959-63. PubMed ID: 12796774
[TBL] [Abstract][Full Text] [Related]
7. Engraftment potential into NOD/SCID mice of CD34+ cells derived from human fetal liver as compared to fetal bone marrow.
Wilpshaar J; Noort WA; Kanhai HH; Willemze R; Falkenburg JH
Haematologica; 2001 Oct; 86(10):1021-8. PubMed ID: 11602407
[TBL] [Abstract][Full Text] [Related]
8. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras.
Ramírez M; Rottman GA; Shultz LD; Civin CI
Exp Hematol; 1998 Apr; 26(4):332-44. PubMed ID: 9546317
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic repopulating ability of cord blood CD34(+) cells in NOD/Shi-scid mice.
Ueda T; Yoshino H; Kobayashi K; Kawahata M; Ebihara Y; Ito M; Asano S; Nakahata T; Tsuji K
Stem Cells; 2000; 18(3):204-13. PubMed ID: 10840074
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD/SCID mice.
Nitsche A; Junghahn I; Thulke S; Aumann J; Radonić A; Fichtner I; Siegert W
Stem Cells; 2003; 21(2):236-44. PubMed ID: 12634420
[TBL] [Abstract][Full Text] [Related]
11. Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34(+) cells from umbilical cord blood as compared to adult sources.
Noort WA; Wilpshaar J; Hertogh CD; Rad M; Lurvink EG; van Luxemburg-Heijs SA; Zwinderman K; Verwey RA; Willemze R; Falkenburg JH
Bone Marrow Transplant; 2001 Jul; 28(2):163-71. PubMed ID: 11509934
[TBL] [Abstract][Full Text] [Related]
12. Identification of long-term repopulating potential of human cord blood-derived CD34-flt3- severe combined immunodeficiency-repopulating cells by intra-bone marrow injection.
Kimura T; Asada R; Wang J; Kimura T; Morioka M; Matsui K; Kobayashi K; Henmi K; Imai S; Kita M; Tsuji T; Sasaki Y; Ikehara S; Sonoda Y
Stem Cells; 2007 Jun; 25(6):1348-55. PubMed ID: 17303816
[TBL] [Abstract][Full Text] [Related]
13. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
[TBL] [Abstract][Full Text] [Related]
14. Intra-bone marrow cotransplantation of donor mesenchymal stem cells in pig-to-NOD/SCID mouse bone marrow transplantation facilitates short-term xenogeneic hematopoietic engraftment.
Eguchi H; Kuroiwa Y; Matsui A; Sada M; Nagaya N; Kawano S
Transplant Proc; 2008 Mar; 40(2):574-7. PubMed ID: 18374132
[TBL] [Abstract][Full Text] [Related]
15. Enhanced engraftment of human cells in RAG2/gammac double-knockout mice after treatment with CL2MDP liposomes.
Rozemuller H; Knaän-Shanzer S; Hagenbeek A; van Bloois L; Storm G; Martens AC
Exp Hematol; 2004 Nov; 32(11):1118-25. PubMed ID: 15539091
[TBL] [Abstract][Full Text] [Related]
16. In vivo engraftment potential of clinical hematopoietic grafts.
Leung W; Ramírez M; Novelli EM; Civin CI
J Investig Med; 1998 Aug; 46(6):303-11. PubMed ID: 9737093
[TBL] [Abstract][Full Text] [Related]
17. Reversible cell surface expression of CD38 on CD34-positive human hematopoietic repopulating cells.
McKenzie JL; Gan OI; Doedens M; Dick JE
Exp Hematol; 2007 Sep; 35(9):1429-36. PubMed ID: 17656009
[TBL] [Abstract][Full Text] [Related]
18. Comparison of hematopoietic activities of human bone marrow and umbilical cord blood CD34 positive and negative cells.
Kim DK; Fujiki Y; Fukushima T; Ema H; Shibuya A; Nakauchi H
Stem Cells; 1999; 17(5):286-94. PubMed ID: 10527463
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
[TBL] [Abstract][Full Text] [Related]
20. A preclinical xenotransplantation animal model to assess human hematopoietic stem cell engraftment.
Angelopoulou MK; Rinder H; Wang C; Burtness B; Cooper DL; Krause DS
Transfusion; 2004 Apr; 44(4):555-66. PubMed ID: 15043572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
